News

Filter

Current filters:

None

7820 to 7829 of 95956 results

Riemser strengthens oncology range with Roche drug

15-02-2012

German drugmaker Riemser Arzneimittel AG is extending its range of supportive cancer therapy products…

Mergers & AcquisitionsOncologyOstacPharmaceuticalRiemser ArztneimittelRoche

Impending biologics patent expiries creates huge opportunity for European biosimilars makers

15-02-2012

The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries…

BiotechnologyEuropeGenericsMarkets & MarketingPatents

Lux Research launches China BioPharma service

15-02-2012

Market intelligence and technology scouting group Lux Research has announced the launch of its new China…

Asia-PacificLicensingLux ResearchPharmaceuticalResearch

Biogen Idec in deal to buy Stromedix

15-02-2012

S biotech firm Biogen Idec (Nasdaq: BIIB) has entered into a definitive agreement to acquire Stromedix,…

Biogen IdecBiotechnologyMergers & AcquisitionsStromedix

US FDA priority review for Truvada for reducing HIV risk

15-02-2012

The US Food and Drug Administration has accepted the supplemental New Drug Application and granted a…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

PhRMA slams US President’s fiscal year 2013 budget plan

15-02-2012

Responding to US President Barack Obama’s fiscal year 2013 budget proposals, Pharmaceutical Research…

FinancialNorth AmericaPharmaceuticalPoliticsRegulation

Watson 4th-quarter beats expectations, with 93% rise in net income

15-02-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) reported a whopping 62% increase to $1.5 billion…

FinancialGenericsWatson Pharmaceuticals

Germany’s IQWiG finds no added benefit for Pfizer’s Xiapex

14-02-2012

In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products…

EuropeInflammatory diseasesPfizerPharmaceuticalRegulationXiapex

FDA approves Merck & Co’s Zioptan

14-02-2012

The US Food and Drug Administration) has approved drug giant Merck & Co’s (NYSE: MRK) Zioptan (tafluprost…

Merck & CoNorth AmericaOphthalmicsPharmaceuticalRegulationSaflutanSanten PharmaceuticalsZioptan

7820 to 7829 of 95956 results

Back to top